- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Cathepsin K (CTSK) is a lysosomal cysteine protease that plays a central role in extracellular matrix degradation, particularly in the breakdown of collagen during bone resorption. The Cathepsin K Antibody / CTSK Lysosomal Protease Antibody is widely used to detect this enzyme in biological systems where proteolytic activity is associated with osteoclast function, tissue remodeling, and disease processes. CTSK is encoded on chromosome 1q21 and belongs to the papain-like cysteine protease family, characterized by potent collagenolytic activity under acidic conditions within lysosomal and resorptive microenvironments.
The Cathepsin K antibody, also referred to as CTSK antibody and osteoclast cathepsin K antibody in the literature, recognizes a protein that is synthesized as a proenzyme and undergoes proteolytic processing to generate an active mature form. This activation occurs within lysosomes or specialized resorption lacunae, where Cathepsin K degrades type I collagen and other matrix proteins. The enzymeâs ability to efficiently cleave triple-helical collagen distinguishes it from other cathepsins and underlies its critical role in skeletal biology.
This Cathepsin K Antibody / CTSK Lysosomal Protease Antibody is uniquely positioned for studies of bone remodeling and matrix degradation. In immunohistochemistry, CTSK is typically observed as granular cytoplasmic staining in osteoclasts and other cells involved in tissue turnover, reflecting its localization within lysosomal compartments. Detection of CTSK provides insight into protease activity associated with bone resorption, inflammatory responses, and pathological remodeling processes.
Cathepsin K is highly expressed in osteoclasts, where it contributes to normal bone turnover by degrading organic bone matrix. Dysregulation of CTSK activity is associated with diseases such as osteoporosis, osteoarthritis, and metastatic bone disease, as well as genetic disorders such as pycnodysostosis. In addition to skeletal tissues, CTSK expression has been reported in certain epithelial and tumor contexts, where it may contribute to extracellular matrix remodeling and tumor invasion.
The mouse monoclonal clone CTSK/2791 provides consistent and specific detection of CTSK, supported by protein microarray specificity validation data demonstrating selective binding to the intended target. This Cathepsin K Antibody / CTSK Lysosomal Protease Antibody is suitable for detecting CTSK expression in research applications where lysosomal protease activity, collagen degradation, and tissue remodeling are of interest. Its performance supports detailed evaluation of CTSK biology across normal and disease-associated contexts.
This Cathepsin K Antibody / CTSK Lysosomal Protease Antibody supports investigation of lysosomal protease activity, extracellular matrix degradation, and disease-associated changes in CTSK expression.
This antibody is part of a broader antibody panel offered by NSJ Bioreagents.
Optimal dilution of the Cathepsin K Antibody / CTSK Lysosomal Protease Antibody to be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
A portion of amino acids 163-274 from the human protein was used as the immunogen for the Cathepsin K antibody.
Store the Cathepsin K antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Cathepsin K antibody, CTSK antibody, Cathepsin K protease antibody, CTSK collagenase antibody, Osteoclast cathepsin K antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.